Epitomee Medical Ltd (EPIT) — Strategic Asset Allocation Index

Latest as of June 2023: 27.9%

Epitomee Medical Ltd (EPIT) has a Strategic Asset Allocation Index of 27.9% as of June 2023. Strategic assets (PP&E of ILA9.74 Million plus long-term investments of ILA-) total ILA9.74 Million, measured against net assets of ILA34.98 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Epitomee Medical Ltd (EPIT) net asset quality to measure how much of total assets are equity-financed.

SAAI

27.9%
Strategic Assets / Net Assets

Strategic Assets

ILA9.74 Million
PP&E + LT Investments

PP&E

ILA9.74 Million
ILA

Net Assets

ILA34.98 Million
ILA

Annual Strategic Asset Allocation Index for Epitomee Medical Ltd (None–None)

The table below presents the year-by-year Strategic Asset Allocation Index for Epitomee Medical Ltd from None to None, covering 0 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See net assets of Epitomee Medical Ltd for net asset value and shareholders' equity analysis.

Year SAAI Strategic Assets (ILA) PP&E LT Investments Net Assets Change (pp)
pp = percentage points